Newsletter Signup x
We need to find new treatments for acute myeloid leukaemia, particularly for children whose disease comes back. Dr Macarena Oporto Espuelas aims to develop a new type of CAR T-cell therapy for relapsed and hard-to-treat AML that is more effective and less toxic to young patients. Her research is funded under the Children with Cancer UK’s Clinical PhD Studentship scheme, which is provided to develop and support future leaders in clinical cancer research.
Identification of novel surface antigen targets for CAR T-cell strategies in paediatric Acute Myeloid Leukaemia stem cells
Dr Macarena Oporto Espuelas
UCL Great Ormond Street Institute of Child Health
London, WC1N 1EH
26 September 2020
36 months
£219,999.99
Patient Story – Lenny
Lenny was diagnosed with T-Cell Non-Hodgkin Lymphoma when he was eight years old in 2018. His dad Daren shares
Read moreCharacterising and targeting treatment resistant cells in Acute Lymphoblastic Leukaemia following treatment
Acute lymphoblastic leukaemia (ALL) is the most common childhood cancer. Most children and young adults with ALL are treated
Read more